Transgene to Present at the 2nd Rodman & Renshaw Annual Global Healthcare Conference

Share Name	Share Symbol	Market	Type
Transgene S.A. ADS (MM)	NASDAQ:TRGNY	NASDAQ	Ordinary Share

Share Name

Share Symbol

Market

Type

Transgene S.A. ADS (MM)

NASDAQ:TRGNY

NASDAQ

Ordinary Share

Price Change

% Change

Share Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

0.00

Transgene to Present at the 2nd Rodman & Renshaw Annual Global Healthcare Conference

26/04/2005 6:01am

PR Newswire (US)

Transgene . (NASDAQ:TRGNY)
Historical Stock Chart

From Jun 2019 to Jun 2024

Transgene to Present at the 2nd Rodman & Renshaw Annual Global Healthcare Conference STRASBOURG, France, April 26 /PRNewswire-FirstCall/ -- Transgene (Nasdaq: TRGNY; Eurolist Paris: FR0005175080) today announced that Dr. Philippe Archinard, Chief Executive Officer, will present at the 2nd Rodman & Renshaw Annual Global Healthcare Conference, on Wednesday May 4, 2005, at 3:10pm at the Intercontinental Hotel in Paris, France. Dr. Philippe Archinard will provide an overview of Transgene's strategy, clinical programs and corporate objectives for 2005. A web cast of Dr. Archinard's presentation will be available live and afterward at: http://www.rodmanandrenshaw.com/rodman.asp?link=Conferences5/ConferenceWebcast ers&bgcolor=wht Transgene, based in Strasbourg, France, is a biopharmaceutical company dedicated to the discovery and development of therapeutic vaccines and immunotherapy products for the treatment of cancer and infectious diseases. Transgene has a broad portfolio of products in clinical development. DATASOURCE: Transgene CONTACT: Philippe Poncet, Chief Financial Officer and Investor Relations of Transgene, +33-0-3-88-27-91-21; or Michael Long of Cohn & Wolfe, +1-415-365-8523; or Tiphaine Hecketsweiler of Image 7, +33-0-1-53-70-74-70, both for Transgene Web site: http://www.transgene.fr/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TRGNY Transgene S.A. ADS (MM)